Spero Ventures is an early-stage venture capital firm based in Burlingame, California, founded in 2018 by Shripriya Mahesh. The firm focuses on investing in mission-driven technology companies across three primary areas: wellbeing, sustainability, and learning, work, and play.

Investment Approach:

Spero Ventures adopts a thesis-driven, conviction-based, and patient investment strategy. They typically lead or co-lead investment rounds ranging from $3 to $10 million, focusing on late seed to Series A stages. Their standard investment check is between $2 to $4 million, with additional capital reserved for follow-on investments in subsequent rounds.

Portfolio Highlights:

The firm’s portfolio includes companies such as:

Corvus Robotics: Specializes in autonomous robots for warehouse logistics.

Spero Therapeutics: A biopharmaceutical company focused on developing therapies for serious diseases.

These investments reflect Spero Ventures’ commitment to supporting innovative solutions in health, sustainability, and technology.

For more information about Spero Ventures and their investment strategies, you can visit their official website.